CME vs JPM: Which Is the Better Dividend Stock?
As of September 2026, JPM (JPMorgan Chase & Co.) screens as the stronger dividend stock, winning 6 of 7 head-to-head metrics. JPM offers the higher yield at 1.89%, CME has the higher dividend-safety score, and JPM trades at the larger discount to fair value (+81%).
| Metric | CME | JPM |
|---|---|---|
| Forward yield | 1.88% | 1.89% |
| Annual dividend | $5.20 | $6.60 |
| Payout ratio | 95% | 26% |
| Years of growth | 15 yr | 15 yr |
| 5-yr dividend growth | 8.0% | 9.0% |
| 5-yr total return | 25% | 106% |
| Dividend safety score | 90 (A) | 82 (A) |
| Fair value estimate | $235.03 | $632.41 |
| Upside to fair value | -15% | +81% |
| Frequency | quarterly | quarterly |
| Market cap | $99.2B | $929.5B |
| P/E ratio | 23.4 | 15.0 |
Higher yield
JPM
1.89%
Safer dividend
CME
Grade A
Faster growth
JPM
9.0%
Better value
JPM
+81% upside
CME vs JPM — FAQ
Related comparisons
See more dividend stock comparisons · data refreshes daily · for informational purposes only, not investment advice.